Targeting Notch and Hedgehog Embryonic Signaling Pathways Has Potent Anti-Tumor Activity in Myeloma and Is Effective in Myeloma Bone Disease.

被引：0

作者：

Schwarzer, Rolf ^{[1
]}

Schuenemann, Nicole ^{[1
]}

Wong, David M. ^{[2
]}

Bogen, Bjarne ^{[3
,4
]}

Bommert, Kurt ^{[5
]}

Doerken, Bernd ^{[1
]}

Manz, Rudolf ^{[2
]}

Jundt, Franziska ^{[1
]}

机构：

[1] Univ Med Berlin, Charite, Dept Hematol & Oncol, Berlin, Germany

[2] Med Univ Lubeck, Inst Syst Inflammat Res, D-23538 Lubeck, Germany

[3] Univ Oslo, Dept Immunol & Transfus Med, Ctr Immune Regulat, Oslo, Norway

[4] Oslo Univ Hosp, Oslo, Norway

[5] Univ Wurzburg, Med Ctr, D-97070 Wurzburg, Germany

来源：

BLOOD | 2012年 / 120卷 / 21期

关键词：

D O I：

10.1182/blood.V120.21.2938.2938

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2938

引用

页数：2

共 46 条

[31] N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma
Edwards, Shanique K. E.
Moore, Carissa R.
Liu, Yan
Grewal, Sukhdeep
Covey, Lori R.
Xie, Ping
[J]. BMC CANCER, 2013, 13
[32] The novel, irreversible proteasome inhibitor PR-171 demonstrates potent anti-tumor activity in pre-clinical models of multiple myeloma, and overcomes bortezomib resistance.
Kuhn, Deborah J.
Chen, Qing
Voorhees, Peter M.
Strader, John S.
Shenk, Kevin D.
Sun, Congcong M.
Demo, Susan D.
Bennett, Mark K.
van Leeuwen, Fred W.
Orlowski, Robert Z.
[J]. BLOOD, 2006, 108 (11) : 987A - 988A
[33] N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myeloma
Shanique K E Edwards
Carissa R Moore
Yan Liu
Sukhdeep Grewal
Lori R Covey
Ping Xie
[J]. BMC Cancer, 13
[34] Anti-DLL4 Has Broad Spectrum Activity in Pancreatic Cancer Dependent on Targeting DLL4-Notch Signaling in Both Tumor and Vasculature Cells
Yen, Wan-Ching
Fischer, Marcus M.
Hynes, Mark
Wu, Jingjiang
Kim, Edward
Beviglia, Lucia
Yeung, V. Pete
Song, Xiaomei
Kapoun, Ann M.
Lewicki, John
Gurney, Austin
Simeone, Diane M.
Hoey, Timothy
[J]. CLINICAL CANCER RESEARCH, 2012, 18 (19) : 5374 - 5386
[35] AUR103 an oral small molecule CD47 antagonist in combination with azacytidine and bortezomib exhibits potent anti-tumor activity in myeloma and leukemia models in vitro and in vivo
Daginakatte, Girish C.
Pottayil, Sasikumar
Naremaddepalli, Sudarshan
Chennakrishnareddy, Gundala
Bilugudi, Prasad
Tangella, Sai Krishna
Patil, Sandeep
Gowda, Nagesh
Aithal, Kiran
Balasubramanian, Wesley Roy
Dhudashiya, Amit
Dodheri, Samiulla
Nellore, Kavitha
Samajdar, Susanta
Ramachandra, Murali
[J]. CANCER RESEARCH, 2022, 82 (12)
[36] AO-176, a Highly Differentiated Clinical Stage Anti-CD47 Antibody, Exerts Potent Anti-Tumor Activity in Preclinical Models of Multiple Myeloma As a Single Agent and in Combination with Approved Therapeutics
Wilson, William Casey
Richards, John
Puro, Robyn J.
Andrejeva, Gabriela
Capoccia, Ben J.
Donio, Mike J.
Hiebsch, Ronald R.
Chakraborty, Prabir
Sung, Victoria
Pereira, Daniel S.
[J]. BLOOD, 2020, 136
[37] Targeting both BET and CBP/EP300 proteins with the novel dual inhibitors NEO2734 and NEO1132 leads to anti-tumor activity in multiple myeloma
Ryan, Katie R.
Giles, Francis
Morgan, Gareth J.
[J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (01) : 90 - 99
[38] Targeting both BET and CBP/EP300 proteins with the novel dual inhibitors NEO2734 and NEO1132 leads to anti-tumor activity in Multiple Myeloma
Ryan, Katie
Dent, Judith
Giles, Francis
Morgan, Gareth
Walker, Brian
[J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E120 - E121
[39] ABC101-1, a novel microtubule inhibitor antibody-drug conjugate targeting HER2, has potent anti-tumor activity in a breast cancer model
Kim, Seo Woo
Yu, Hana
Lee, Geon Ho
Lim, Tae Gyu
Jeong, Minji
Hwang, Hyeonjoo
Moon, Jee Eun
Lee, Yong Beom
Jin, Sung-Ha
Jeong, Jin Hyun
[J]. CANCER RESEARCH, 2024, 84 (03)
[40] Potent Anti-Tumor Activity of Bcma CAR-T Therapy Against Heavily Treated Multiple Myeloma and Dynamics of Immune Cell Subsets Using Single-Cell Mass Cytometry
Hu, Yongxian
Zhang Yanlei
Wei, Guoqing
Hong, Chang Alex
Huang, He
[J]. BLOOD, 2019, 134

← 1 2 3 4 5 →